Perrigo Remains Committed To Splitting Off Prescription Despite Delay

Perrigo has pushed back plans to split off its Prescription business as part of its transformation into a consumer self-care focused company.

Clock_Nail
Nailing Down Plans To Split Off Perrigo’s Prescription Unit Has Taken Longer Than Expected • Source: Shutterstock

Perrigo insists that it is still committed to plans to split off its Prescription pharmaceuticals business, whether as a sale or a spin-off, despite pushing back such a move while it evaluates timing amid uncertainty and tumult in the US generics market.

“The Rx [Prescription] separation continues to be a strategic priority,” said Perrigo’s president and CEO Murray Kessler, “and we continue...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business